PROVENGE

NDC 30237-8900 · Dendreon Pharmaceuticals LLC

Generic namesipuleucel-T

Dosage formINJECTION

RouteINTRAVENOUS

Active ingredient(s)SIPULEUCEL-T

Strength50000000 1/1

Pharmacologic classAutologous Cellular Immunotherapy [EPC], Cell-mediated Immunity [PE], Cells, Cultured, Autologous [EXT], Leukocytes, Mononuclear [CS]

Marketing categoryBLA

Packages

30237-8900-6 — 1 BAG in 1 CARTON (30237-8900-6) / 1 INJECTION in 1 BAG (30237-8900-5)

Billed under HCPCS

Q2043 — Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion Medicare Part B payment limit (ASP + 6%): $55932.43

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.